> Pipelines
Platform Technology
Systemically Administration Platform Technology
In general, most systemically administered viruses fail to reach tumor tissues, owing to rapid clearance by host immune system and poor tumor tropism of the viruses
GeneMedicine has developed a proprietary nanomaterial-based platform technology that enables effective and tumor-targeted systemic administration of oncolytic viruses
This system attenuates nonspecific sequestration of systemically administered virus in normal tissues and exponentially improves intratumoral accumulation of the virus, thus leading to superior safety profile and antitumor efficacy
Systemically Administered OV Data
